|
|||||
|
|
Cardiovascular morbidity,heart rates and use of antimuscarinics in patients with overactive bladder |
|
| Authors: | Karl‐Erik Andersson Chaitanya Sarawate Kristijan H. Kahler Elizabeth L. Stanley Amit S. Kulkarni |
| Affiliation: | 1. Wake Forest University, Winston Salem, NC, HealthCore, Inc, Wilmington, DE, and;2. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA |
| Abstract: | |
| Keywords: | overactive bladder OAB antimuscarinic cardiovascular comorbidities |